Puregraf 150IU Injection (Menotrophin)
| Active Ingredient | Menotrophin |
|---|---|
| Manufacturers | Gufic Biosciences Ltd. |
| Indications | Female infertility |
| Strength | 150iu |
| Packaging | 1 Injection in 1 vial |
| Delivery Time | 6 To 15 days |
Puregraf 150IU Injection contains Menotrophin, a hormonal treatment used in fertility therapy. Menotrophin is a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential in stimulating the ovaries to produce mature eggs in women and supporting sperm production in men.
This medication is commonly used in assisted reproductive techniques such as IVF (in vitro fertilization) and ovulation induction. Puregraf is administered by subcutaneous or intramuscular injection under medical supervision.
Dosage and frequency depend on the patient’s response to treatment, monitored closely by a fertility specialist. It’s important to follow your doctor’s instructions and not to self-administer without guidance.
Possible side effects may include abdominal discomfort, mild bloating, headache, or injection site irritation. In rare cases, ovarian hyperstimulation syndrome (OHSS) may occur, especially in women undergoing fertility treatment.
Puregraf 150IU helps enhance reproductive outcomes and is a trusted choice in fertility care, improving the chances of conception for hopeful couples.








There are no reviews yet.